Lipid peroxides, glutathione peroxidase, high density lipoprotein subfractions and apolipoproteins in young adults. 1990

P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
Department of Medicine, University of Oulu, Finland.

Lipid peroxides have been implicated in the initiation of atherogenesis. In this study of 23 young healthy subjects, high levels of serum lipid peroxides were associated with low serum HDL2 cholesterol concentrations and low HDL2/HDL3 cholesterol and apolipoprotein A-I/A-II ratios. Low levels of LDL cholesterol and apolipoprotein B, and low apolipoprotein B/A-I ratios were typical of subjects with high serum glutathione peroxidase activities. Serum lipid peroxide levels varied widely in subjects without abnormal cholesterol, HDL cholesterol or LDL cholesterol concentrations. This variation may play a role in the frequent occurrence of coronary artery disease in normolipidaemic individuals.

UI MeSH Term Description Entries
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005979 Glutathione Peroxidase An enzyme catalyzing the oxidation of 2 moles of GLUTATHIONE in the presence of HYDROGEN PEROXIDE to yield oxidized glutathione and water. Cytosolic Glutathione Peroxidase,Glutathione Lipoperoxidase,Selenoglutathione Peroxidase,Glutathione Peroxidase, Cytosolic,Lipoperoxidase, Glutathione,Peroxidase, Glutathione,Peroxidase, Selenoglutathione
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
March 1986, Preventive medicine,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
October 1988, Research communications in chemical pathology and pharmacology,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
August 1987, Journal of the National Medical Association,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
June 1993, The American journal of medicine,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
December 1992, Cardiovascular drugs and therapy,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
January 1978, Biochemical Society transactions,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
July 1988, The Journal of clinical endocrinology and metabolism,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
January 1987, The Journal of laboratory and clinical medicine,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
August 1999, Current opinion in lipidology,
P V Luoma, and J Stengård, and H Korpela, and A Rautio, and E A Sotaniemi, and E Suvanto, and J Marniemi
December 1990, Biochemical Society transactions,
Copied contents to your clipboard!